Tolerogenic property of MHC class I and class II molecules: Lessons from a gene therapy approach

Frontiers in Bioscience

Volumn 12, Issue 8, 2007, Pages 3133-3139

  LeGuern, Christian ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Gene therapy; Major histocompatibility complex; MHC; Peptides; Regulatory T cells; Review; T cell tolerance

Indexed keywords

ANIMALIA; RODENTIA;

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ALLELE; ANIMAL; GENE THERAPY; GENETICS; HUMAN; IMMUNOLOGY; REGULATORY T LYMPHOCYTE; REVIEW;

ALLELES; ANIMALS; GENE THERAPY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; T-LYMPHOCYTES, REGULATORY;

EID: 34347221199     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2301     Document Type: Review

References (47)

1. Cavazzana-Calvo, M., S. Hacein-Bey, B. de Saint, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J. L. Casanova, P. Bousso, F. L. Deist & A. Fischer: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288, 669-672 (2000) (Pubitemid 30241569)
2. Aiuti, A., S. Slavin, M. Aker, F. Ficara, S. Deola, A. Mortellaro, S. Morecki, G. Andolfi, A. Tabucchi, F. Carlucci, E. Marinello, F. Cattaneo, S. Vai, P. Servida, R. Miniero, M. G. Roncarolo & C. Bordignon: Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science, 296, 2410-3 (2002) (Pubitemid 34734219)
3. May, C., S. Rivella, J. Callegari, G. Heller, K. M. Gaensler, L. Luzzatto & M. Sadelain: Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature, 406, 82-86 (2000) (Pubitemid 30460215)
4. Pawliuk, R., K. A. Westerman, M. E. Fabry, E. Payen, R. Tighe, E. E. Bouhassira, S. A. Acharya, J. Ellis, I. M. London, C. J. Eaves, R. K. Humphries, Y. Beuzard, R. L. Nagel & P. Leboulch: Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy. Science, 294, 2368-2371 (2001) (Pubitemid 33140563)
5. Andersson, G., B. M. Illigens, K. W. Johnson, D. Calderhead, C. LeGuern, G. Benichou, M. E. White-Scharf & J. D. Down: Non-myeloablative conditioning is sufficient to allow engraftment of Egfp-expressing bone marrow and subsequent acceptance of Egfp-transgenic skin grafts in mice. Blood, 101, 4305-4312 (2003) (Pubitemid 36857794)
6. Fraser, C. C., M. Sykes, R. S. Lee, D. H. Sachs & C. LeGuern: Specific unresponsiveness to retrovirallytransferred class I antigen is controlled through the helper pathway. J Immunol, 154, 1587-1595 (1995)
7. Sykes, M., D. H. Sachs, A. W. Nienhuis, D. A. Pearson, A. D. Moulton & D. M. Bodine: Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation, 55, 197-202 (1993) (Pubitemid 23033971)
8. Charlton, B., H. Auchincloss, Jr & C. G. Fathman: Mechanisms of transplantation tolerance. Ann. Rev. Immunol., 12, 707-736 (1994)
9. Sonntag, K. C., D. W. Emery, A. Yasumoto, G. W. Haller, S. Germana, T. Sablinski, A. Shimizu, K. Yamada, H. Shimada, S. Arn, D. H. Sachs & C. LeGuern: Tolerance to solid organ transplants through transfer of MHC class II genes. J. Clin. Invest., 107, 65-71 (2001) (Pubitemid 32047415)
10. Ierino, F. L., S. Gojo, P. T. Banerjee, M. Giovino, Y. Xu, J. Gere, C. Kaynor, M. Awwad, R. Monroy, J. Rembert, T. Hatch, A. Foley, T. Kozlowski, K. Yamada, F. A. Neethling, J. Fishman, M. Bailin, T. R. Spitzer, D. K. Cooper, A. B. Cosimi, C. LeGuern & D. H. Sachs: Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers. Transplantation, 67, 1119-1128 (1999) (Pubitemid 29205573)
11. Kang, E. S. & J. Iacomini: Induction of central deletional T cell tolerance by gene therapy. J Immunol, 169, 1930-5 (2002) (Pubitemid 34857656)
12. LeGuern, C., Y. Akiyama, K. Tanaka, S. Germana, Y. Iwamoto, L. Fernandez, H. S. & G. Benichou: Intracellular MHC class II controls regulatory tolerance to allogeneic transplants, submitted, (2007)
13. Cresswell, P.: Antigen processing and presentation. Immunol Rev, 207, 5-7 (2005) (Pubitemid 41415003)
14. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella & V. H. Engelhard: Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science, 255, 1261-3 (1992)
15. DiBrino, M., K. C. Parker, J. Shiloach, M. Knierman, J. Lukszo, R. V. Turner, W. E. Biddison & J. E. Coligan: Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc Natl Acad Sci U S A, 90, 1508-12 (1993) (Pubitemid 23058202)
16. Hunt, D. F., H. Michel, T. A. Dickinson, J. Shabanowitz, A. L. Cox, K. Sakaguchi, E. Appella, H. M. Grey & A. Sette: Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science, 256, 1817-20 (1992)
17. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor & S. Stevanovic: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics, 50, 213-9 (1999) (Pubitemid 30099526)
18. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. Vignali, W. S. Lane & J. L. Strominger: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med, 178, 27-47 (1993) (Pubitemid 23173241)
19. Chicz, R. M., R. G. Urban, W. S. Lane, J. C. Gorga, L. J. Stern, D. A. Vignali & J. L. Strominger: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature, 358, 764-8 (1992)
20. Inaba, K., S. Turley, F. Yamaide, T. Iyoda, K. Mahnke, M. Inaba, M. Pack, M. Subklewe, B. Sauter, D. Sheff, M. Albert, N. Bhardwaj, I. Mellman & R. M. Steinman: Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med, 188, 2163-73 (1998) (Pubitemid 28562532)
21. Mellman, I. & R. M. Steinman: Dendritic cells: specialized and regulated antigen processing machines. Cell, 106, 255-8 (2001) (Pubitemid 32772607)
22. Sercarz, E. E. & E. Maverakis: Mhc-guided processing: binding of large antigen fragments. Nat Rev Immunol, 3, 621-9 (2003) (Pubitemid 37328665)
23. Santambrogio, L., A. K. Sato, G. J. Carven, S. L. Belyanskaya, J. L. Strominger & L. J. Stern: Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci U S A, 96, 15056-61 (1999) (Pubitemid 30019764)
24. Pierre, P. & I. Mellman: Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell, 93, 1135-45 (1998) (Pubitemid 28307419)
25. Rider, B. J., E. Fraga, Q. Yu & B. Singh: Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules. Mol Immunol, 33, 625-33 (1996) (Pubitemid 26323847)
26. Chicz, R. M., W. S. Lane, R. A. Robinson, M. Trucco, J. L. Strominger & J. C. Gorga: Self-peptides bound to the type I diabetes associated class II MHC molecules HLADQ1 and HLA-DQ8. Int Immunol, 6, 1639-49 (1994) (Pubitemid 24357876)
27. Agrawal, B., M. Manickasundari, E. Fraga & B. Singh: T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice. J Immunol, 147, 383-390 (1991)
28. Benichou, G., K. M. Malloy, R. C. Tam, P. S. Heeger & E. V. Fedoseyeva: The presentation of self and allogeneic MHC peptides to T lymphocytes. Hum Immunol, 59, 540-8 (1998) (Pubitemid 28420531)
29. Marrack, P., L. Ignatowicz, J. W. Kappler, J. Boymel & J. H. Freed: Comparison of peptides bound to spleen and thymus class II. J Exp Med, 178, 2173-83 (1993) (Pubitemid 23344875)
30. Rudensky, A. Y., S. Rath, P. Preston-Hurlburt, D. B. Murphy & C. A. Janeway, Jr.: On the complexity of self. Nature, 353, 660-662 (1991) (Pubitemid 21912583)
31. Murphy, D. B., S. Rath, E. Pizzo, A. Y. Rudensky, A. George, J. K. Larson & C. A. Janeway, Jr.: Monoclonal antibody detection of a major self peptide. MHC class II complex. J Immunol, 148, 3483-91 (1992)
32. Benichou, G., P. A. Takizawa, P. T. Ho, C. C. Killion, C. A. Olson, M. Mcmillan & E. E. Sercarz: Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J Exp Med, 172, 1341-1346 (1990) (Pubitemid 20366208)
33. Benoist, C. & D. Mathis: Positive selection of the T cell repertoire: where and when does it occur? Cell, 58, 1027-33 (1989) (Pubitemid 19238180)
34. Bensinger, S. J., A. Bandeira, M. S. Jordan, A. J. Caton & T. M. Laufer: Major histocompatibility complex class IIpositive cortical epithelium mediates the selection of CD4 (+) 25 (+) immunoregulatory T cells. J Exp Med, 194, 427-38 (2001) (Pubitemid 32835039)
35. Hsieh, C. S., Y. Liang, A. J. Tyznik, S. G. Self, D. Liggitt & A. Y. Rudensky: Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity, 21, 267-77 (2004) (Pubitemid 39094055)
36. Altman, E., S. Germana, C. Baron, I. M. McMorrow, K. Yamada, F. Preffer & C. LeGuern: Role of MHC Class II in Regulatory Tolerance to Class II-matched Transplants, submitted, (2007)
37. Chaturvedi, P., B. Agrawal, M. Zechel, E. Lee-Chan & B. Singh: A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice. J Immunol, 164, 6610-20 (2000) (Pubitemid 30408848)
38. Gonzalez-Gay, M. A., G. H. Nabozny, M. J. Bull, E. Zanelli, J. Douhan, 3rd, M. M. Griffiths, L. H. Glimcher, H. S. Luthra & C. S. David: Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis. J Exp Med, 180, 1559-64 (1994)
39. Zanelli, E., C. J. Krco & C. S. David: Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition. J Immunol, 158, 3545-51 (1997) (Pubitemid 127484077)
40. Ochando, J. C., C. Homma, Y. Yang, A. Hidalgo, A. Garin, F. Tacke, V. Angeli, Y. Li, P. Boros, Y. Ding, R. Jessberger, G. Trinchieri, S. A. Lira, G. J. Randolph & J. S. Bromberg: Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol, 7, 652-62 (2006) (Pubitemid 43797347)
41. LeGuern, C.: Regulation of T Lymphocyte Functions by MHC Class II Self-Presentation. Trends Immunol, 24, 633-8 (2003) (Pubitemid 37485912)
42. Marshall, E.: Clinical research. Gene therapy a suspect in leukemia-like disease. Science, 298, 34-5 (2002)
43. Imren, S., M. E. Fabry, K. A. Westerman, R. Pawliuk, P. Tang, P. M. Rosten, R. L. Nagel, P. Leboulch, C. J. Eaves & R. K. Humphries: High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells. J Clin Invest, 114, 953-62 (2004) (Pubitemid 39578723)
44. Steinman, R. M., D. Hawiger & M. C. Nussenzweig: Tolerogenic dendritic cells. Annu Rev Immunol, 21, 685-711 (2003) (Pubitemid 37174545)
45. Cui, Y., J. Golob, E. Kelleher, Z. Ye, D. Pardoll & L. Cheng: Targeting transgene expression to antigenpresenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood, 99, 399-408 (2002) (Pubitemid 34533073)
46. Veron, P., S. Boutin, J. Bernard, O. Danos, J. Davoust & C. Masurier: Efficient transduction of monocyte-and CD34 (+) - derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation. J Gene Med (2006)
47. Tian, C., J. Bagley, D. Forman & J. Iacomini: Induction of central tolerance by mature T cells. J Immunol, 173, 7217-22 (2004) (Pubitemid 39628157)